{"id":5630,"date":"2014-11-26T12:49:34","date_gmt":"2014-11-26T11:49:34","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=5630"},"modified":"2014-11-26T12:49:34","modified_gmt":"2014-11-26T11:49:34","slug":"actavis-dopo-deal-allergan-si-prepara-licenziare-punta-cina","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/actavis-dopo-deal-allergan-si-prepara-licenziare-punta-cina\/","title":{"rendered":"After the deal on Allergan, Actavis is preparing to lay off. And focus on China"},"content":{"rendered":"

However, he did not go into the details of the possible restructuring. According to Saunders, there is overlap between the two companies in areas such as human resources and finance.<\/i>
\nFTA Online News\u00a0<\/b>
\n25\/11\/2014 International Stock Exchanges \u2013 ECONOMY THE PRESS<\/a><\/p>\n

\"\"Actavis is preparing to reduce its workforce and expand business in China, according to as declared by the chief executive Brent Saunders to Bloomberg<\/a> Television. The generics maker, which has reached an agreement to take over Allergan, the maker of Botox, in a $66 billion deal, has not, however, gone into details of the possible restructuring. According to Saunders, there is overlap between the two companies in areas such as human resources and finance.<\/p>\n

(RR)<\/p>","protected":false},"excerpt":{"rendered":"

Non \u00e8 per\u00f2 entrato nei dettagli della possibile ristrutturazione. Secondo Saunders esistono sovrapposizioni tra le due societ\u00e0 in comparti come risorse umane e finanza. FTA Online News\u00a0 25\/11\/2014 \u00a0 Borse Internazionali\u00a0 – ECONOMIA LA STAMPA Actavis si prpara a ridurre la sua forza lavoro e a espandere il business in Cina, secondo quanto dichiarato dal …<\/p>","protected":false},"author":4,"featured_media":5633,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[53,31,27],"class_list":["post-5630","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-fusioniacquisizioni","tag-generici","tag-licenziati"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/5630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=5630"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/5630\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/5633"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=5630"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=5630"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=5630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}